Targeting human cancer cells using novel compounds designed to bind to Sigma-1 receptors that are overexpressed in tumors.
Presentation
- Overview
Overview
Date/time Interval
- 2019-04-01
Occurs Within Event
Participant
- Frampton, Arthur Ronald Presenter 2019-04-01